November 2017

  • ALS – (Amyotrophic Lateral Sclerosis) Findings-2010 May

    ALS – (Amyotrophic Lateral Sclerosis) Findings-2010 May

    Preclinical data is encouraging that cannabis has powerful benefits to assist ALS by modifying the disease reducing symptoms prolonging life. Learn more .http://journals.sagepub.com/doi/pdf/10.1177/1049909110369531  

    Know More

  • ALS – (Amyotrophic Lateral Sclerosis) Study-2017 Feb

    Study Reviews Evidence Supporting Use of Cannabinoids to Treat ALS

    Know More

  • Cannabis in ALS Treatment-2017 Feb

    In 2017, How Cannabis Helps Ease Symptoms Of Lou Gehrig’s Disease (ALS) BACKGROUND: Based on the currently available scientific data, it is reasonable to think that cannabis might significantly slow the progression of ALS, potentially extending life expectancy and substantially reducing the overall burden of the disease. You can read the full article here => https://herb.co/2017/02/01/cannabis-lou-gehrigs-disease-als/

    Know More

  • Cannabis & ALS-2015 Jun

    In 2015, How Does Cannabis Impact the Progression of ALS? BACKGROUND: Based on some exciting new anecdotal evidence, the use of cannabis oil to treat ALS may actually prolong the life of the patient in addition to relieving many of the disease’s devastating day-to-day symptoms. You can read the full article here => https://www.leafly.com/news/science-tech/the-medical-minute-how-does-cannabis-impact-the-progression-of-al

    Know More

  • Parkinson’s Research-2016 Jun

    In 2016, data showed that there is a complex and likely autocatalytic inflammatory response within nerve cells and that this early form of proteotoxicity can be blocked by the activation of cannabinoid receptors. Background: used a proteotoxicity model based upon the inducible expression of Aβ in a human central nervous system nerve cell line to characterize a…

    Know More

  • Huntington Disease Research-2016 Jun

    In 2016, Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids BACKGROUND: We hypothesized that proteotoxicity in nerve cells themselves may initiate an inflammatory response that can lead directly to their death and contribute to overall inflammation in the CNS. The following experiments identify the molecular basis of this inflammatory response using a human CNS nerve cell…

    Know More

  • Alzheimer’s Research-2016 Jun

    n 2016, Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids BACKGROUND: We hypothesized that proteotoxicity in nerve cells themselves may initiate an inflammatory response that can lead directly to their death and contribute to overall inflammation in the CNS. The following experiments identify the molecular basis of this inflammatory response using a human CNS nerve cell…

    Know More

  • Alzheimer’s Research-2014 Aug

    In 2014, Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice BACKGROUND: The non-psychoactive phytocannabinoid cannabidiol (CBD) exerts neuroprotective, anti-oxidant and anti-inflammatory effects and promotes neurogenesis. CBD also reverses Aβ-induced spatial memory deficits in rodents. You can read the full article here => http://link.springer.com/article/10.1007%2Fs00213-014-3478-5

    Know More

  • Alzheimer’s Research-2006

    In 2006, A Molecular Link Between the Active Component of Marijuana and Alzheimer’s Disease Pathology BACKGROUND: Here, we demonstrate that the active component of marijuana, Δ9-tetrahydrocannabinol (THC), competitively inhibits the enzyme acetylcholinesterase (AChE) as well as prevents AChE-induced amyloid β-peptide (Aβ) aggregation, the key pathological marker of Alzheimer’s disease. You can read the full article here => https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2562334/

    Know More

  • Cannabis & ADHD Research-2008

    Cannabis & ADHD Research-2008

    In 2008, this case investigation was to highlight that people with ADHD can benefit in some cases from the consumption of THC and can even lead to an enhanced driving performance. BACKGROUND:  A 28-year old male, who had numerous driving vilations did Performance tests, which were conducted with the test batteries ART2020 and TAP to evluate ability…

    Know More